Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes.
K Karberg, J Zochling, J Sieper, D Felsenberg… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To define the relationship between bone growth (syndesmophytes) and bone
loss (osteoporosis) in ankylosing spondylitis (AS). METHODS: Bone mineral density (BMD) at …
loss (osteoporosis) in ankylosing spondylitis (AS). METHODS: Bone mineral density (BMD) at …
Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the National Database of the German Collaborative Arthritis Centres
S Ziegler, D Huscher, K Karberg, A Krause… - Annals of the …, 2010 - ard.bmj.com
Background New strategies and options for the treatment of rheumatoid arthritis (RA) have
evolved during the past decade. A study was undertaken to investigate to what extent this …
evolved during the past decade. A study was undertaken to investigate to what extent this …
[HTML][HTML] B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
…, E Schrezenmeier, K Karberg… - Arthritis & …, 2022 - Wiley Online Library
Objective Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX)
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …
Sensitivity and Specificity of Autoantibodies Against CD 74 in Nonradiographic Axial Spondyloarthritis
…, HH Euler, M Fleck, R Hein, K Karberg… - Arthritis & …, 2019 - Wiley Online Library
Objective Autoantibodies against CD 74 (anti‐ CD 74) are associated with ankylosing spondylitis
( AS ). The present multicenter study, the International Spondyloarthritis Autoantibody (…
( AS ). The present multicenter study, the International Spondyloarthritis Autoantibody (…
[HTML][HTML] A real-world rheumatology registry and research consortium: the German RheumaDatenRhePort (RHADAR) registry
…, A Zink, G Gauler, P Wurth, P Aries, K Karberg… - Journal of Medical …, 2021 - jmir.org
Real-world data are crucial to continuously improve the management of patients with
rheumatic and musculoskeletal diseases (RMDs). The German RheumaDatenRhePort (RHADAR) …
rheumatic and musculoskeletal diseases (RMDs). The German RheumaDatenRhePort (RHADAR) …
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo …
…, J Thiel, C Glaser, E Feist, GR Burmester, K Karberg… - The Lancet, 2024 - thelancet.com
Background Individuals with anti-citrullinated protein antibodies (ACPAs) and subclinical
inflammatory changes in joints are at high risk of developing rheumatoid arthritis. Treatment …
inflammatory changes in joints are at high risk of developing rheumatoid arthritis. Treatment …
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial spa: a prospective multicentre cross-sectional study
…, H Haibel, H Käding, K Karberg… - Therapeutic …, 2022 - journals.sagepub.com
Objectives: The objective of the study was to validate the Ankylosing Spondylitis Disease
Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay (ASDAS-…
Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay (ASDAS-…
Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from …
K Thiele, K Albrecht, A Zink, M Aringer, K Karberg… - RMD open, 2022 - rmdopen.bmj.com
Objective To analyse the performance of the rheumatoid arthritis impact of disease (RAID)
score in patients with ankylosing spondylitis, polymyalgia rheumatica, systemic lupus …
score in patients with ankylosing spondylitis, polymyalgia rheumatica, systemic lupus …
Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012
…, KC Albrecht, S Bischoff, A Krause, K Karberg… - RMD open, 2015 - rmdopen.bmj.com
Objectives To describe changes in drug treatment and clinical outcomes of ankylosing
spondylitis (AS) during the past decade. Methods The national database of the German …
spondylitis (AS) during the past decade. Methods The national database of the German …
[HTML][HTML] B cell characteristics at baseline predict vaccination response in RTX treated patients
…, E Schrezenmeier, K Karberg… - Frontiers in …, 2022 - frontiersin.org
Background Vaccination is considered as most efficient strategy in controlling SARS-CoV-2
pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases …
pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases …